Addex Therapeutics (ADXN) Other Working Capital Changes (2019 - 2026)

Addex Therapeutics has reported Other Working Capital Changes for 6 years, with the latest figure at -$5.0 billion in Q4 2024.

• Quarterly Other Working Capital Changes fell 158.25% year-over-year to -$5.0 billion in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$12.9 billion (down 1117.6% YoY) and the FY2025 annual result came in at -$8705.8, up 91.96% from the prior year.
• Other Working Capital Changes declined to -$5.0 billion in Q4 2024 per ADXN's latest filing, from $5.1 billion in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $480.5 billion in Q2 2024 and troughed at -$815.3 billion in Q2 2023.
• A 5-year average of -$16.8 billion and a median of $115685.6 in 2022 frame the typical range for Other Working Capital Changes.
• The sharpest annual moves came in 2023 and 2024: Other Working Capital Changes surged 77543277.44% in 2023, then plunged 1751415272.5% in 2024.
• Over 5 years, Other Working Capital Changes stood at $1.0 million in 2020, then sank by 75.25% to $252654.3 in 2021, then slumped by 104.79% to -$12104.4 in 2022, then soared by 71323162.91% to $8.6 billion in 2023, then tumbled by 158.25% to -$5.0 billion in 2024.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered -$5.0 billion, $5.1 billion, and $358.5 billion for Q4 2024, Q3 2024, and Q2 2024 respectively.